FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileDecoy Therapeutics Inc. Common Stock
  • Company Overview
  • Financial Data
  • Ownership & News
  • Discussion
DCOY
Decoy Therapeutics Inc. Common Stock Stock AnalysisComprehensive stock analysis for Decoy Therapeutics Inc. Common Stock (DCOY) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisDCOY
DCOY
Decoy Therapeutics Inc. Common Stock
  • Company Overview
  • Financial Data
  • Ownership & News
  • Discussion
DCOY
  1. Home
  2. Stocks
  3. Decoy Therapeutics Inc. Common Stock
DC

Decoy Therapeutics Inc. Common Stock

🇺🇸DCOY•NASDAQ
DC

Decoy Therapeutics Inc. Common Stock

🇺🇸DCOY•NASDAQ
Market cap
$441.21K

Your view on DCOY

Mkt Cap
$441.21K
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Decoy Therapeutics Inc. Common Stock

Industry
Not available
Sector
Not available
CEO
Not available
Headquarters
US
Industry
Not available
Sector
Not available
CEO
Not available
Headquarters
US
Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Decoy Therapeutics Inc. Common Stock. Starting points for Decoy Therapeutics Inc. Common Stock: EPS -$19.59, beta 0.58. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Decoy Therapeutics Inc. Common Stock. Trailing twelve-month EPS for Decoy Therapeutics Inc. Common Stock stands at -$19.59. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Decoy Therapeutics Inc. Common Stock. Decoy Therapeutics Inc. Common Stock has reported as a listed company since 2015. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Decoy Therapeutics Inc. Common Stock, and how their positions are changing. At a $441,214 market value, institutional positions materially move Decoy Therapeutics Inc. Common Stock's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Decoy Therapeutics Inc. Common Stock executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Decoy Therapeutics Inc. Common Stock. Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Decoy Therapeutics Inc. Common Stock.

DCOY AnalysisFair
Past
1
Growth
2
Health
5
Profit
1
Value
1